| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,010,401 | 1,212,157 | 1,295,932 | 1,513,387 | | Cost of Revenue | 892,866 | 1,079,286 | 1,151,775 | 1,349,011 | | | Gross Profit | 117,535 | 132,871 | 144,157 | 164,376 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 36,956 | 56,689 | 65,133 | 43,985 | | Non Recurring | (18,901) |
-
|
-
|
-
| | Others | 6,080 | 5,866 | 5,607 | 6,360 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 93,400 | 70,316 | 73,417 | 114,031 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 398 | 344 | 448 | 1,249 | | Earnings Before Interest And Taxes | 74,874 | 82,658 | 80,791 | 122,139 | | Interest Expense | 4,916 | 5,557 | 5,546 | 6,580 | | Income Before Tax | 69,958 | 77,101 | 75,245 | 115,559 | | Income Tax Expense | 28,070 | 32,061 | 25,180 | 46,058 | | Minority Interest | (1,065) | (1,616) | (1,253) | (920) | | | | Net Income From Continuing Ops | 40,823 | 43,424 | 48,812 | 68,581 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 40,823 | 43,424 | 48,812 | 68,581 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $40,823 | $43,424 | $48,812 | $68,581 |
|
1.48% Nasdaq 0.00%
Income Statement
